Crystal structure of the therapeutical antibody fragment of canakinumab in its unbound state


Domain Annotation: ECOD Classification ECOD Database Homepage

ChainsFamily NameDomain Identifier ArchitecturePossible HomologyHomologyTopologyFamilyProvenance Source (Version)
B [auth L]Prenyltransfe4g5zL1 A: alpha arraysX: GIY-YIG endonucleaseH: GIY-YIG endonucleaseT: GIY-YIG endonucleaseF: PrenyltransfECOD (v295.2)
A [auth H]Prenyltransfe4g5zH1 A: alpha arraysX: GIY-YIG endonucleaseH: GIY-YIG endonucleaseT: GIY-YIG endonucleaseF: PrenyltransfECOD (v295.2)

Domain Annotation: CATH CATH Database Homepage

ChainDomainClassArchitectureTopologyHomologyProvenance Source (Version)
B [auth L]2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (4.3.0)
A [auth H]2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (4.3.0)

IMGT Antibody Annotation IMGT Database Homepage

ChainProtein NameDescriptionOrganism NameGene Allele Name(s)Domain Name(s)Receptor TypeReceptor DescriptionProvenance Source
B [auth L]INN name L-KAPPA Homo sapiens (human) IGKV6-21*01, IGKV6D-21*01, IGKV6D-21*02, IGKJ3*01, IGKC*01 V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA IG FAB-GAMMA-1_KAPPA IMGT (202633-0)
A [auth H]INN name VH-CH1 Homo sapiens (human) IGHV3-33*01, IGHV3-33*04, IGHJ4*01, IGHJ4*02, IGHJ4*03, IGHG1*03 V-DOMAIN VH, C-DOMAIN CH1 IG FAB-GAMMA-1_KAPPA IMGT (202633-0)

SAbDab Antibody Annotation SAbDab Database Homepage

ChainChain ClassChain SubclassChain TypeAntigen Name(s) Provenance Source
B [auth L]Light ChainIGKV1 Kappa-SAbDab (2026-08-28)
A [auth H]Heavy ChainIGHV3 --SAbDab (2026-08-28)

Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage

ChainNameTargetProvenance Source
B [auth L] Canakinumab IL1BTherapeutic SAbDab (2026-08-28)
A [auth H] Canakinumab IL1BTherapeutic SAbDab (2026-08-28)